What is the recommended dose for Kemadrine (procyclidine)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Kemadrine (Procyclidine) Dosing

For adults, the standard dose of procyclidine (Kemadrine) is 2.5 mg three times daily initially, which can be increased gradually to a typical maintenance dose of 5 mg three times daily (15 mg/day total), with a maximum of 20-30 mg/day in divided doses if needed for control of extrapyramidal symptoms.

Standard Adult Dosing

  • Initial dose: Start with 2.5 mg orally three times daily after meals 1
  • Maintenance dose: Increase gradually to 5 mg three times daily (total 15 mg/day) based on response and tolerability 1
  • Maximum dose: Can be increased up to 20-30 mg/day in divided doses if necessary for adequate control of parkinsonian symptoms 2, 1

Clinical Context

Procyclidine is an anticholinergic medication primarily used to manage extrapyramidal side effects (EPS) induced by antipsychotic medications 1. The drug effectively prevents and treats drug-induced parkinsonism, including rigidity, tremor, and akinesia 1.

Key Dosing Considerations

  • Dose titration: Adjust the dose gradually based on individual response to minimize anticholinergic side effects while achieving adequate symptom control 1
  • Timing: Administer doses after meals to reduce gastrointestinal side effects 1
  • Prophylactic use: When used prophylactically in patients on long-term antipsychotic therapy, procyclidine significantly reduces the incidence of EPS (0% vs 54% with placebo) 1

Important Clinical Caveats

Cognitive Effects

  • Higher doses impair information processing: Procyclidine at 15 mg single dose significantly impairs prepulse inhibition (a measure of early sensory processing) in both healthy volunteers and patients with schizophrenia, while 10 mg does not 3, 4
  • Use minimum effective dose: Given the cognitive disruption at higher doses, maintain patients on the lowest dose that adequately controls EPS 3, 4

Withdrawal Considerations

  • Do not abruptly discontinue: Sudden withdrawal in patients on chronic therapy results in EPS development in 54% of cases within three weeks, including akinesia in 27% 1
  • Risk of misdiagnosis: Akinesia from procyclidine withdrawal can be mistaken for negative symptoms of schizophrenia or depression 1

Common Pitfalls to Avoid

  • Avoid using standard doses in elderly patients: Older patients may require lower doses due to increased sensitivity to anticholinergic effects
  • Monitor for anticholinergic toxicity: Watch for confusion, urinary retention, constipation, dry mouth, and blurred vision, especially at higher doses
  • Consider abuse potential: Procyclidine has documented abuse potential in some populations and should be monitored accordingly 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.